Author

A. M. Sholukh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

A. A. A. Aguzzi· 1 shared A. Ilsley· 1 shared A. Iwasaki· 1 shared A. K. Lynn· 1 shared A. MacCamy· 1 shared A. McGuire· 1 shared A. S. Morgunov· 1 shared D. Burton· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. A. A. Aguzzi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration

S. Fiedler, S. R. A. Devenish, A. S. Morgunov, A. Ilsley, F. Ricci, M. Emmenegger, V. Kosmoliaptsis, E. S. Theel, J. R. Mills, A. M. Sholukh, A. A. A. Aguzzi, A. Iwasaki, A. K. Lynn, T. P. J. Knowles

The paper links antiviral activity of therapeutic antibodies to their affinity and concentration by comparing them to serological fingerprints in convalescent sera.

bioRxiv · Feb 3, 2022Biochemistry

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.

N. Hurlburt, L. Homad, I. Siha, M. F. Jenewein, A. MacCamy, Y.-H. Wan, J. Boonyaratanakornkit, A. M. Sholukh, P. Zhou, D. Burton, R. Andrabi, L. Stamatatos, M. Pancera, A. McGuire

This paper identifies a conserved neutralizing epitope on the spike S2 subunit of sarbecoviruses, demonstrating cross-neutralization against multiple variants and a bat coronavirus.

bioRxiv · Aug 2, 2021Immunology